Literature DB >> 30105070

Natural Products as a Source for New Leads in Cancer Research and Treatment.

Célia Cabral1,2,3, Thomas Efferth4, Isabel M Pires5, Patricia Severino6, Marco F L Lemos7.   

Abstract

Entities:  

Year:  2018        PMID： 30105070      PMCID： PMC6076959          DOI： 10.1155/2018/8243680

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN： 1741-427X            Impact factor:   2.629


× No keyword cloud information.
  7 in total

1.  Discovery of honokiol thioethers containing 1,3,4-oxadiazole moieties as potential α-glucosidase and SARS-CoV-2 entry inhibitors.

Authors:  Ting Xu; Jie-Ru Meng; Wanqing Cheng; Jia-Zheng Liu; Junyan Chu; Qian Zhang; Nannan Ma; Li-Ping Bai; Yong Guo
Journal:  Bioorg Med Chem       Date:  2022-05-21       Impact factor: 3.461

2.  Chemical, biological and in silico assessment of Ocimum viride essential oil.

Authors:  Madhulika Bhagat; Monica Sangral; Ajay Kumar; Rafiq A Rather; Khushboo Arya
Journal:  Heliyon       Date:  2020-06-23

Review 3.  Honokiol: A Review of Its Anticancer Potential and Mechanisms.

Authors:  Chon Phin Ong; Wai Leong Lee; Yin Quan Tang; Wei Hsum Yap
Journal:  Cancers (Basel)       Date:  2019-12-22       Impact factor: 6.639

4.  The Tobacco β-Cembrenediol: A Prostate Cancer Recurrence Suppressor Lead and Prospective Scaffold via Modulation of Indoleamine 2,3-Dioxygenase and Tryptophan Dioxygenase.

Authors:  Ethar A Mudhish; Abu Bakar Siddique; Hassan Y Ebrahim; Khaldoun S Abdelwahed; Judy Ann King; Khalid A El Sayed
Journal:  Nutrients       Date:  2022-04-04       Impact factor: 5.717

5.  Phytochemical Profile and In Vitro Antioxidant, Antimicrobial, Vital Physiological Enzymes Inhibitory and Cytotoxic Effects of Artemisia jordanica Leaves Essential Oil from Palestine.

Authors:  Nidal Jaradat
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

Review 6.  A Review on Worldwide Ephedra History and Story: From Fossils to Natural Products Mass Spectroscopy Characterization and Biopharmacotherapy Potential.

Authors:  Khaoula Elhadef; Slim Smaoui; Mariam Fourati; Hajer Ben Hlima; Ahlem Chakchouk Mtibaa; Imen Sellem; Karim Ennouri; Lotfi Mellouli
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-30       Impact factor: 2.629

7.  Comparative Gene Signature of (-)-Oleocanthal Formulation Treatments in Heterogeneous Triple Negative Breast Tumor Models: Oncological Therapeutic Target Insights.

Authors:  Mohammed H Qusa; Khaldoun S Abdelwahed; Abu Bakar Siddique; Khalid A El Sayed
Journal:  Nutrients       Date:  2021-05-18       Impact factor: 5.717
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.